Objectives: Remimazolam is an ultra-short-acting benzodiazepine recently approved for endoscopic procedures in Japan as a sedative agent. We aimed to compare the efficacy and safety of remimazolam and midazolam for endoscopic ret... ...

请注册登录后继续浏览